Deutsche Bank AG FF - Post Stabilisation Notice -Bayer EUR 30NC6 & 30NC9

HSBC Holdings

Yesterday 08:48

RNS Number : 8592Z
  
Deutsche Bank AG, Frankfurt
  
21 October 2026
  
 


21st October 2026
 
 
Not for distribution, directly or indirectly, in or into the United States or

any jurisdiction in which such distribution would be unlawful.
 
Bayer Aktiengesellschaft
(the Issuer)
 
Post-stabilisation Period Announcement
 
Further to the pre-stabilisation period announcement dated 23rd September 2026, Deutsche Bank AG, Frankfurt (contact: Debt Syndicate, Phone No. +44 207 547 6885) hereby gives notice that no stabilisation (within the meaning of Article 3.2(d) of the Market Abuse Regulation (EU/596/2014)), and also as it forms part of UK domestic law by virtue of the European Union (Withdrawal) Act 2018 was undertaken by the Stabilisation Manager(s) named below in relation to the offer of the following securities.
 
 




The Securities:


















Issuer:


Bayer Aktiengesellschaft














Guarantor (if any):


















Aggregate nominal amount:


EUR 2bn














Description:


Bayer EUR 1bn 30NC6 & EUR 1bn EUR 30NC9




 
ISIN Code:


 
XS3385867794 / XS3385867877














Issue/reoffer price:


99.629% / 99.497%




 
Spread over benchmark:


 
DBR 1.7% Aug-32 +243.2 bps / DBR 2.6% Aug-35 +282.3 bps




 
Stabilisation:


















Stabilising Manager(s):


BNP PARIBAS, BofA Securities, Citigroup, Crédit Agricole CIB, Deutsche Bank, HSBC




 
This announcement is for information purposes only and does not constitute an invitation or offer to underwrite, subscribe for or otherwise acquire or dispose of any securities of the Issuer in any jurisdiction.
 
This announcement is not an offer of securities for sale into the United States. The securities referred to above have not been, and will not be, registered under the United States Securities Act of 1933 and may not be offered or sold in the United States absent registration or an exemption from registration. There has not been and will not be a public offer of the securities in the United States.




This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
  END
 
 
STAEAXEFASFKFEA